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Background: The features of carotid atherosclerosis in ketosis-onset diabetes have not been investigated. Our aim
was to evaluate the prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed Chinese
diabetic patients with ketosis but without islet-associated autoantibodies.
Methods: In total, 423 newly diagnosed Chinese patients with diabetes including 208 ketosis-onset diabetics
without islet-associated autoantibodies, 215 non-ketotic type 2 diabetics and 79 control subjects without diabetes
were studied. Carotid atherosclerosis was defined as the presence of atherosclerotic plaques in any of the carotid
vessel segments. Carotid intima-media thickness (CIMT), carotid atherosclerotic plaque formation and stenosis were
assessed and compared among the three groups based on Doppler ultrasound examination. The clinical features of
carotid atherosclerotic lesions were analysed, and the risk factors associated with carotid atherosclerosis were
evaluated using binary logistic regression in patients with diabetes.
Results: The prevalence of carotid atherosclerosis was significantly higher in the ketosis-onset diabetic group
(30.80%) than in the control group (15.2%, p=0.020) after adjusting for age- and sex-related differences, but no
significant difference was observed in comparison to the non-ketotic diabetic group (35.8%, p=0.487). The mean
CIMT of the ketosis-onset diabetics (0.70±0.20 mm) was markedly higher than that of the control subjects
(0.57±0.08 mm, p<0.001), but no significant difference was found compared with the non-ketotic type 2 diabetics
(0.73±0.19 mm, p=0.582) after controlling for differences in age and sex. In both the ketosis-onset and the
non-ketotic diabetes, the prevalence of carotid atherosclerosis was markedly increased with age (both p<0.001)
after controlling for sex, but no sex difference was observed (p=0.479 and p=0.707, respectively) after controlling for
age. In the ketosis-onset diabetics, the presence of carotid atherosclerosis was significantly associated with age,
hypertension, low-density lipoprotein cholesterol and mean CIMT.
Conclusions: The prevalence and risk of carotid atherosclerosis were significantly higher in the ketosis-onset
diabetics than in the control subjects but similar to that in the non-ketotic type 2 diabetics. The characteristics of
carotid atherosclerotic lesions in the ketosis-onset diabetics resembled those in the non-ketotic type 2 diabetics.
Our findings support the classification of ketosis-onset diabetes as a subtype of type 2 diabetes.
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In recent decades, a ketosis-prone form of diabetes that
does not necessarily fit the typical characteristics of au-
toimmune type 1 diabetes mellitus has been identified.
Because the aetiology of this form of diabetes is unclear
and the classic markers of autoimmune destruction of
islet beta cells are also absent, the World Health Orga-
nization and the American Diabetes Association have
classified this subtype as “idiopathic Type 1 diabetes” or
“Type 1B” [1]. However, growing evidence, including
older age at onset, higher rates of obesity and genetic
predisposition among affected individuals, suggest that
this atypical form of diabetes should be considered as a
subset of type 2 diabetes, or ketosis-prone type 2 dia-
betes [2,3].
Although the metabolic and autoimmune characte-
ristics of ketosis-prone type 2 diabetes have been well
documented [3-6], little is known concerning the preva-
lence and clinical features of atherosclerosis in ketosis-
prone type 2 diabetics. It is well-established that diabetes
mellitus is an independent risk factor for atherosclerosis
and cardiovascular disease [7-10]. Several studies have
demonstrated that patients with diabetes are at higher
risk for atherosclerosis and cardiovascular disease in com-
parison to normal subjects [11-15]. According to our pre-
vious study, the prevalence of atherosclerosis detected by
ultrasound examination was nearly 80% in hospitalised
type 2 diabetics [16]. However, few studies have investi-
gated the prevalence and clinical characteristics of athero-
sclerosis in patients with ketosis-prone type 2 diabetes.
Thus, one of the aims of the present study was to
investigate the prevalence of carotid atherosclerosis in
newly diagnosed Chinese patients with diabetes compa-
red with control individuals. Secondly, our study aimed
to investigate differences in carotid atherosclerosis and
compare clinical, anthropometric and metabolic differ-
ences between the ketosis-onset and the non-ketotic
type 2 diabetics. Finally, we aimed to evaluate the clinical
features of carotid atherosclerosis and to determine the
risk factors for carotid atherosclerosis in both ketosis-
onset and non-ketotic diabetic patients.
Materials and methods
Subjects and study design
This was a cross-sectional study and was partly based
on data obtained in our previous study [16]. Between
January 2007 and October 2008, 497 Chinese patients
(≥17 years old) newly diagnosed with diabetes were hos-
pitalised in our department. According to the criteria of
the World Health Organization [1], newly diagnosed dia-
betes was defined as having either fasting plasma glucose
(FPG) ≥ 7.0 mmol/L and/or 2-h postprandial plasma
glucose (2-h PPG) ≥ 11.1 mmol/L in subjects without a
history of diabetes. Diabetic ketosis was defined as thepresence of hyperglycaemia and moderate to heavy urine
ketones (0.5 mmol/L-15 mmol/L). Patients with conco-
mitant conditions that might result in ketosis were ex-
cluded. These conditions included gestational diabetes,
renal insufficiency, corticoid therapy, and infectious dis-
ease. Ketosis-onset diabetes was defined as diabetes with
the presence of diabetic ketosis and in the absence of
glutamic acid decarboxylase (GAD) and thyrosin phos-
phatase (IA-2) autoantibodies. Non-ketotic type 2 diabe-
tes was defined as diabetes with neither diabetic ketosis
nor GAD or IA-2 autoantibodies. Of these 497 patients,
55 patients who were positive for islet-associated auto-
antibodies were excluded, and 19 patients who did not
meet other criteria were also excluded. The other 423
patients with diabetes were classified into two categor-
ical groups based on the presence or absence of diabetic
ketosis when diagnosed with diabetes. Of these patients,
208 were diagnosed for ketosis-onset diabetes and 215
were diagnosed for non-ketotic type 2 diabetes. In addi-
tion, 79 control participants with a FPG < 6.0 mmol/L
and a 2-h plasma glucose < 7.8 mmol/L during a 75 g oral
glucose tolerance test were age-matched to the patients
with ketosis-onset diabetes.
All subjects were interviewed to obtain their history of
hypertension, alcohol consumption and smoking habits.
Smoking included both current and former smokers.
Likewise, alcohol use included current and former use of
alcohol. The study was approved by the human research
ethics committee of the hospital, and informed consent
was obtained from all subjects.
Physical examination and laboratory measurements
Physical examinations measuring weight, height, waist cir-
cumference, hip circumference and blood pressure were
performed by our previous method [16]. Body mass index
(BMI) was calculated as weight divided by height squared.
The waist-to-hip ratio (WHR) was calculated as waist cir-
cumference divided by hip circumference. Underweight
was defined as a BMI of less than 18.5 kg/m2, overweight
as 23 to 24.9 kg/m2, and obesity as above 25 kg/m2 based
on the Asia-Pacific criteria set by the World Health
Organization [17]. Hypertension was defined according to
our previously described criteria [16].
All patients with diabetes were screened for IA-2 and
GAD autoantibodies at the time of admission. The
autoantibodies against GAD and IA-2 were measured
by ELISA (EUROIMMUN Medizinische Labordiagnos-
tika AG, Germany). Urine ketones were measured by
Legal’s test.
Venous blood samples were collected after an overnight
fast and 2 h after breakfast. Fasting Glycosylated hemo-
globin A1C (HbA1c), fasting C-peptide (FCP), 2-h post-
prandial C-peptide (2-h PCP), fasting plasma glucose
(FPG), 2-h postprandial plasma glucose (2-h PPG), total
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lipoprotein cholesterol (HDL-C), and low-density lipo-
protein cholesterol (LDL-C) were measured by standard
laboratory methods.
Ultrasonography measurements
Each subject was submitted to carotid artery Doppler ul-
trasound examination. Carotid ultrasonography was per-
formed by three experienced ultra-sonographers under a
standardised protocol. Colour Doppler sonography was
performed with an Acuson Sequoia 512 scanner (Siemens
Medical Solutions, Mountain View, CA) equipped with a
5–13 MHz linear array transducer.
All subjects were examined in a supine position with
their head turned 45 degrees from the site being scanned.
Carotid arteries were examined bilaterally at the common
carotid arteries, the bifurcation, the external carotid arter-
ies, and the internal carotid arteries from transverse and
longitudinal orientations and were scanned in the antero-
lateral, posterolateral and mediolateral directions to assess
the presence of atherosclerotic plaque and stenosis and
measure CIMT. Measurements were made manually on
still images magnified to standard size on-line. The IMT
was defined as the distance between the leading edge of
the lumen-intima echo and the leading edge of the media-
adventitia echo. The mean CIMT was defined as the mean
of the right and left IMT of the common carotid artery.
The common carotid artery IMT was measured on-line in
the posterior wall 10–20 mm proximal to the carotid bi-
furcation in a region free of focal plaque. Three measu-
rements were made on each side, and the values were
averaged to produce a mean IMT for each side. According
to the Mannheim consensus [18], atherosclerotic plaques
were defined as focal structures encroaching into the ar-
terial lumen of 0.5 mm or 50% of the surrounding IMT
value or IMT of > 1.5 mm. Carotid atherosclerosis was de-
fined as the presence of atherosclerotic plaques in any of
the aforementioned arterial segments. Carotid stenosis
was defined as any degree of narrowing in either the
internal, external or common carotid arteries by carotid
plaques. Both intra-observer and inter-observer reprodu-
cibility were determined using a Spearman correlation co-
efficient. The intra-observer correlation coefficients were
0.91-0.92 for carotid IMT, 0.88-0.89 for the identification
of carotid plaques, and 0.87-0.94 for the identification of
carotid stenosis. The inter-observer correlation coeffi-
cients were 0.87-0.97 for carotid IMT, 0.83-0.94 for the
identification of carotid plaques, and 0.82-0.89 for the
identification of carotid stenosis.
Statistical analyses
The SPSS 11.0 software was used for statistical analysis.
A p-value less than 0.05 was considered as statistically
significant. Data are presented as the mean ± S.D., andmedian values are provided for skewed data. Contingen-
cy table analyses with chi-square tests were used to as-
sess differences in the relative frequencies of categorical
variables. Binary or multinomial logistic regression was
applied to assess differences of categorical variables while
adjusting for age and/or sex. Normality was checked for
continuous variables. If the data were distributed nor-
mally, one-way ANOVA with LSD was used to compare
quantitative data among three groups, and independent
sample t tests were used for comparisons of continuous
variables between two groups. The Mann–Whitney U test
was used if the data were not distributed normally. Linear
regression was used to evaluate differences of continuous
variables while adjusting for age and/or sex. The Mantel-
Haenszel Common Odds Ratio Estimate was used to as-
sess the odds ratio of carotid atherosclerosis while con-
trolling for the effects of age and sex. Binary logistic
regression analysis was performed to investigate the asso-
ciations between risk factors for atherosclerosis and ca-
rotid atherosclerosis.
Results
Characteristics of study subjects
The clinical characteristics of the studied subjects are
presented in Table 1. Both the control group and the
non-ketotic type 2 diabetic group had an equal sex dis-
tribution, whereas the ketosis-onset diabetic group had a
strong predominance of males, even after adjusting for
age. The ketosis-onset diabetic patients had significantly
higher FPG, 2-h PPG and HbA1c levels than the non-
ketotic type 2 diabetic patients (all p<0.001). The le-
vels of FCP and 2-h PCP were markedly lower in the
ketosis-onset diabetic patients than in the non-ketotic
diabetic patients before and after adjusting for age and sex
(all p<0.001).
Comparison of carotid atherosclerosis
The comparison of carotid atherosclerosis among the
control group, the ketosis-onset diabetic group and non-
ketotic diabetic group after adjustment for age and sex
is shown in Figure 1. The prevalence of carotid athe-
rosclerosis in the ketosis-onset diabetic group was sig-
nificantly higher than in the control group (p=0.020),
but no significant difference was observed between the
ketosis onset and non-ketotic type 2 diabetic groups
(p=0.487) (Figure 1A). The odds ratio of carotid athero-
sclerosis was higher in the patients with ketosis-onset
diabetes than in the control group (OR, 2.25; 95% CI,
1.48-4.23; P=0.024), but the odds ratio of carotid athero-
sclerosis between ketosis-onset and non-ketotic diabetics
did not differ significantly (Figure 1B). In contrast to
carotid atherosclerosis, there was no significant diffe-
rence in the prevalence of carotid stenosis among the
control group (0.0%), the ketosis-onset diabetic group
Table 1 Characteristics of study subjects
Variables Control subjects Ketosis-onset type 2 diabetes Non-ketotic type 2 diabetes P value *P value #P value
(n=79) (n=208) (n=215)
Male (%) 46 (58.2%) 153 (73.6%) 122 (56.7%) 0.001 0.009 0.01
Age (years) 50±7 49±15 56±14 <0.001 <0.001 <0.001
Smoking (n, %) 44 (55.7%) 84 (40.4%) 65 (30.2%) <0.001 <0.001 0.740
Alcohol (n, %) 44 (55.7%) 37 (17.8%) 36 (16.7%) <0.001 <0.001 0.311
Hypertension (%) 17 (21.5%) 81 (38.9%) 98 (45.6%) 0.001 0.026 0.685
BMI (kg/m2) 24.64±3.5 25.05±3.54 25.16±3.59 0.548 0.095 0.251
WHR 0.90±0.05 0.91±0.06 0.91±0.06 0.051 0.128 0.894
Weight category 0.648 0.365 0.631
underweight 0 (0.00%) 3 (1.4%) 2 (0.9%) —— —— ——
overweight 23 (29.1%) 48 (23.1%) 48 (22.3%) —— —— ——
obesity 32 (40.5%) 97 (46.6%) 109 (50.7%) —— —— ——
SBP (mmHg) 129±14 127±15 130±17 0.162 0.907 0.523
DBP (mmHg) 84±12 81±11 81±9 0.039 0.073 0.729
*TG (mmol/l) 1.52 (1.05-2.04) 1.44 (1.00-2.19) 1.49 (1.08-2.21) 0.711 0.394 0.831
TC (mmol/l) 5.05±1.10 5.03±1.22 4.82±1.22 0.163 0.080 0.035
HDL (mmol/l) 1.45±0.34 1.05±0.27 1.11±0.25 <0.001 <0.001 0.390
LDL (mmol/l) 3.78±1.24 3.40±1.03 3.12±0.97 <0.001 <0.001 0.002
*FPG (mmol/l) 5.36 (5.00-5.66) 9.74 (7.63-12.45) 7.53 (6.39-9.67) <0.001 <0.001 <0.001
*2h PPG (mmol/l) 5.00 (4.48-6.08) 16.66 (12.94-20.79) 13.14 (10.39-16.66) <0.001 <0.001 <0.001
*FCP —— 1.23 (0.74-1.92) 2.02 (1.36-2.93) <0.001 <0.001 <0.001
*2h PCP —— 2.31 (1.55-3.66) 4.65 (3.12-6.35) <0.001 <0.001 <0.001
HA1C (%) 5.44±0.43 11.83±2.05 9.81±2.58 <0.001 <0.001 <0.001
Values are expressed as the mean±S.D, median with interquartile range, or percentages. * Non-normal distribution of continuous variables.
P-value: The p-values were not adjusted for age and sex for the trend.
*P-value: The *p-values were adjusted for age and sex for the trend.
#P-value: The #p-values were adjusted for age and sex for ketosis-onset type 2 diabetes vs.non-ketotic type 2 diabetes.
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(Figure 1C). Similar to carotid atherosclerosis, the mean
CIMT in the ketosis-onset diabetics (0.70±0.20 mm) was
significantly greater than that of the control subjects
(0.57±0.08 mm, p<0.001), but no significant difference
was found in comparison to the non-ketotic type 2 dia-
betic subjects (0.73±0.19 mm, p=0.582) (Figure 1D).
Comparison of clinical characteristics between the
subjects with and without carotid atherosclerosis
The clinical and laboratory characteristics of the studied
subjects with and without carotid atherosclerosis in each
group are shown in supplementary data (Additional file 1:
Table S1). In the ketosis-onset diabetic group, variables
that were significantly different between the subjects with
and without carotid atherosclerosis included age, hyper-
tension, SBP, LDL-C, and FPG. Interestingly, similar to the
ketosis-onset diabetic group, variables in the non-ketotic
type 2 diabetic group that were significantly different be-
tween the subjects with and without carotid atheroscle-
rosis also included age, hypertension, and SBP.Comparison of mean CIMT between the subjects with and
without carotid atherosclerosis
Figure 2 compares the mean CIMT value of subjects with
and without carotid atherosclerosis in each group. In both
the ketosis-onset (0.64±0.18 mm and 0.82±0.19 mm for
the subjects without and with carotid atherosclerosis, re-
spectively, p=0.003) and non-ketotic (0.67±0.18 mm and
0.83±0.18 mm for the subjects without and with carotid
atherosclerosis, respectively, p=0.005) diabetic groups, the
mean CIMT value was markedly higher in the subjects
with carotid atherosclerosis than in the subjects without
carotid atherosclerosis.
Analyses of carotid atherosclerotic lesions and risk factors
for carotid atherosclerosis in type 2 diabetes
The analyses of carotid atherosclerotic lesions with re-
spect to sex and age in type 2 diabetes are shown in
Figure 3. There was no significant difference in the mean
CIMT and the prevalence of carotid atherosclerotic pla-
ques and stenosis in patients with diabetes between the
sexes (Figure 3A, C and E). To the contrary, the mean
Figure 1 Comparison of carotid atherosclerotic lesions among the three groups after adjusting for age and sex. (A) Comparison of the
prevalence of carotid atherosclerosis among the three groups. The p-value for three group comparisons was 0.045. (B) Odds ratio of carotid
atherosclerosis for the ketosis-onset and the non-ketotic type 2 diabetic subjects in comparison to control subjects without diabetes. The bars
represent the 95% confidence interval. Compared with control subjects, where *p=0.024 and **p=0.041. (C) Comparison of the prevalence of
carotid atherosclerotic stenosis among the three groups. The p-value for three group comparisons was 0.738 (D) Comparison of mean CIMT
among the three groups. The p-value for three group comparisons was <0.001.
Li et al. Cardiovascular Diabetology 2013, 12:18 Page 5 of 10
http://www.cardiab.com/content/12/1/18CIMT and the prevalence of carotid atherosclerotic pla-
ques significantly increased with age in diabetic patients
(Figure 3B and D). However, there was no significant
age-related difference in the prevalence of carotid sten-
osis in diabetic patients (Figure 3F).
A multivariate analysis of variables associated with ca-
rotid atherosclerosis in the diabetic patients is shown in
Table 2. According to the analyses, statistically signifi-
cant risk factors for carotid atherosclerosis were age,
hypertension, LDL-C, and mean CIMT in the ketosis-
onset diabetics, and age, hypertension and mean CIMT
were risk factors in the non-ketotic diabetics. For all typeFigure 2 Comparison of mean CIMT between subjects with and witho2 diabetics studied, diabetic ketosis was not a risk factor
for carotid atherosclerosis.
Discussion
Atypical or ketosis-prone type 2 diabetes was first re-
ported by Winter et al. in 1987 in black Americans [19]
and is distinguishable from other subtypes of diabetes
by clinical, immunological, and biological features. It has
since been reported in other ethnicities such as Native-
Americans, Chinese, and Hispanics [20-22]. Atypical
ketosis-prone diabetes is frequently detected in obese in-
dividuals and characterised by an acute onset with eitherut carotid atherosclerosis.
Figure 3 Comparison of carotid atherosclerotic lesions stratified by sex and age in type 2 diabetics. (A) The prevalence of carotid
atherosclerosis stratified by sex in ketosis-onset and non-ketotic type 2 diabetic subjects after adjusting for age. (B) The prevalence of carotid
atherosclerosis stratified by age in ketosis-onset and non-ketotic type 2 diabetic subjects after adjusting for sex. The p-values for group
comparisons were all <0.001 in both the ketosis-onset and the non-ketotic type 2 diabetic subjects. (C) Comparison of mean CIMT stratified
by sex in ketosis-onset and non-ketotic type 2 diabetic subjects after adjusting for age. (D) Comparison of mean CIMT stratified by age in
ketosis-onset and the non-ketotic type 2 diabetic subjects after adjusting for sex. The p-values for group comparisons were all <0.001 in both the
ketosis-onset and the non-ketotic type 2 diabetics. (E) The prevalence of carotid atherosclerotic stenosis stratified by sex in ketosis-onset and
non-ketotic type 2 diabetic subjects after adjusting for age. (F) The prevalence of carotid atherosclerotic stenosis stratified by age in ketosis-onset
and non-ketotic type 2 diabetic subjects after adjusting for sex. The p-values for group comparisons were 0.560 and 0.626 in the ketosis-onset
and the non-ketotic type 2 diabetics, respectively.
Table 2 A multivariate analysis of variables associated with carotid atherosclerosis
Variables Ketosis-onset type 2 diabetes Non-ketotic type 2 diabetes Total type 2 diabetes
OR 95% CI p value OR 95% CI p value OR 95% CI p value
Sex 1.25 0.43-3.67 0.679 2.39 0.79-7.27 0.124 1.73 0.83-3.59 0.145
Age 1.05 1.01-1.09 0.006 1.10 1.05-1.15 <0.001 1.07 1.04-1.10 <0.001
Hypertension 3.00 1.12-8.02 0.029 1.34 1.81-5.53 0.045 1.98 1.57-6.85 0.037
LDL-C 1.56 1.01-2.40 0.046 1.23 0.77-1.98 0.392 1.37 1.01-1.86 0.045
Mean CIMT 9.73 1.08-87.55 0.042 19.42 2.69-94.11 0.007 16.18 3.14-83.44 0.001
Diabetic ketosis 0.95 0.50-1.80 0.881
Binary logistic regression analyses were performed with the presence of carotid atherosclerosis as the dependent variable and with risk factors including age, sex,
hypertension, SBP, BMI, HDL-C, LDL-C, FPG, FCP, HA1C, mean CIMT, and diabetic ketosis as independent variables. The table only includes sex and variables
significantly associated with carotid atherosclerosis.
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atypical ketosis-prone diabetes lack markers associated
with islet cell autoimmunity.
The clinical, metabolic, and immunological characte-
ristics of atypical ketosis-prone diabetes have been well
studied by other investigators [4,21,22,24]. However, con-
troversy exists concerning the classification of atypical
ketosis-prone diabetes because the disease possesses fea-
tures associated with both type 1 and type 2 diabetes.
Atypical ketosis-prone diabetes was previously classified
as idiopathic Type 1 diabetes by the World Health Or-
ganization and the American Diabetes Association [1].
On the other hand, some researchers think that atyp-
ical ketosis-prone diabetes is a subtype of type 2 dia-
betes that develops in patients with high sensitivity to
glucotoxicity or lipotoxicity or with dysregulated glu-
cagon secretion [2,3,6]. Furthermore, the prevalence and
features of atherosclerosis in both type 1 and type 2 dia-
betes are well-documented, but those in patients with
ketosis-prone type 2 diabetes remain unknown and have
not been investigated. Thus, in the current study we fo-
cused our attention on investigating the prevalence and
clinical characteristics of carotid atherosclerosis in pa-
tients with diabetic ketosis but without islet autoantibo-
dies at onset. To the best of our knowledge, this is the first
report to describe the prevalence and clinical characteris-
tics of atherosclerosis in ketosis-onset type 2 diabetes.
General clinical features
Because our subjects were negative for islet-associated
autoantibodies, the relationship between ketosis-onset
and a transient dysfunction of islet cells through an au-
toimmune process was considered to be unlikely in our
studied cohorts. Therefore, we proposed two distinct dia-
betic groups based on presence or absence of diabetic ke-
tosis. The prevalence of ketosis-prone type 2 diabetes is
not known, but our findings indicated that what was once
described as “atypical diabetes” is in fact a common clin-
ical phenomenon affecting nearly 50% of Chinese patients
with newly diagnosed diabetes in our study. The reason
that nearly half of newly diagnosed diabetic subjects had
ketosis-onset is that the condition of ketosis-onset diabetic
subjects tended to be more serious, and these patients
were thus more likely to be hospitalised.
The patients with ketosis-onset diabetes showed an
earlier onset, with a mean age of 49 years considering
that the mean age of the patients with non-ketotic type
2 diabetes was 56 years old. Most importantly, unlike
cases of typical type 1 and type 2 diabetes, which display
a similar sex distribution, ketosis-onset diabetes shows a
stronger prevalence in males consistently with previous
reports [5,25-27]. Additionally, consistent with several
previous studies [25,26], we also found that there were
higher blood glucose levels and lower plasma C-peptidelevels in ketosis-onset diabetics compared with the non-
ketotic type 2 diabetics, which indicated the insulin se-
cretion function of islets was impaired at onset in the
patients with ketosis-prone diabetes. The acute impair-
ment of β-cell function in ketosis-prone diabetes has been
found to be the major determinant of ketosis onset [24].
Although the underlying mechanisms of impaired islet
β-cell function have not been elucidated, an increased sus-
ceptibility to glucose toxicity or lipotoxicity might result
in the transient functional abnormalities of islet β-cells
[25,27,28].
On the other hand, there were many similarities in the
clinical characteristics between the ketosis-onset diabe-
tics and the non-ketotic type 2 diabetics. For example,
the proportion of overweight and obesity in the ketosis-
onset diabetics was similar to that of the non-ketotic
type 2 diabetics. Obesity was present in 46.6% of the ke-
tosis-onset diabetic patients in our study, which was very
close to the findings of Winter and colleagues [19]. Add-
itionally, both BMI and WHR were also similar between
the two groups, which indicated that individuals with
ketosis-prone diabetes physically resemble those with
type 2 diabetes. Likewise, we observed older age, a higher
proportion of hypertension, higher SBP, and a greater
mean CIMT value in subjects with carotid atherosclerosis
than in those without carotid atherosclerosis, and this was
shared by between ketosis-onset and non-ketotic type 2
diabetic groups.
Carotid atherosclerotic lesions
Previous studies have described the prevalence of carotid
atherosclerosis in both type 1 and type 2 diabetes, but
there are very few reports available for ketosis-prone
type 2 diabetes. Thus, we further evaluated the preva-
lence and clinical features of carotid atherosclerosis in
ketosis-onset diabetes. Our results demonstrated a sig-
nificantly increased prevalence of carotid atherosclerosis
in newly diagnosed diabetic patients with ketosis-onset
compared with the control subjects without diabetes but
not in comparison to the non-ketotic diabetic patients.
Moreover, the diabetic patients with ketosis-onset had a
nearly 2.3-fold increased risk of carotid atherosclerosis
in comparison to the control subjects consistent with
findings of other studies of typical type 2 diabetic pa-
tients. On the contrary, when compared with the non-
ketotic type 2 diabetes, the risk of carotid atherosclerosis
was not markedly increased or decreased in the ketosis-
onset diabetes. In a population-based study, carotid ath-
erosclerosis was present in 58% of the study subjects
[29]. A study by Lundman et al. [30] showed that 28% of
type 2 diabetic patients had one or more carotid plaques.
After a 2-year follow-up, the prevalence of carotid pla-
ques increased to 62%, including patients who initially had
plaques. It is well-established that carotid artery plaques
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strong predictors of cardiovascular events [29,31,32]. A
large population-based study has demonstrated a signifi-
cant association between the presence of carotid plaques
and the risk of vascular events [32]. Similar to other stu-
dies [33-35], the prevalence of carotid atherosclerosis also
significantly increased with age in the patients with keto-
sis-onset diabetes, but there was no significant difference
between sexes in our study which may be due to uneven
gender distribution in diabetic patients with ketosis-onset
[5,25,27]. Given that carotid atherosclerosis is associated
with an increased risk of cardiovascular disease and is also
a powerful predictor for future cardiovascular events, the
presence of carotid atherosclerosis in ketosis-prone dia-
betic patients may contribute to the improved prediction
of the future risk of vascular events.
In contrast to carotid atherosclerosis, the prevalence of
carotid stenosis was low in both newly diagnosed ketosis-
onset diabetics and non-ketotic type 2 diabetics, and no
significant difference was noted among the three groups
studied. The estimated prevalence of carotid artery sten-
osis varies to a great extent in different studies and is de-
pendent on the definition of carotid stenosis, the method
for measuring stenosis, and the selected study populations
[13,36,37]. In the Tromsø Study, the prevalence of carotid
stenosis was 5.3% in men and 3.8% in women in the gen-
eral population [36]. Lacroix et al. demonstrated that the
prevalence of carotid stenosis <60% and ≥ 60% was 63.6%
and 4.7% in type 2 diabetic patients without any history of
cerebrovascular disease, respectively [37], which was far
higher than that of our study subjects. This discrepancy
was partly explained by the fact that our study subjects
were newly diagnosed with diabetes although atheroscler-
otic stenosis is more frequently detected in the diabetic
patients with a long history of diabetes. Furthermore, the
prevalence of carotid stenosis is significantly higher in
men than in women and increases with age as shown in
other studies [36,37]. In our study, although the preva-
lence of carotid stenosis stratified by sex and age was not
statistically significant different in the patients with keto-
sis-onset diabetes, the prevalence of carotid stenosis was
also higher in men (3.9%) than in women (0.0%). Likewise,
the prevalence of carotid stenosis increased with age in
patients with ketosis-onset diabetes. Given that ketosis-
onset diabetes has a strong male predominance, the above
results may be due to small samples and uneven gender
distribution in the ketosis-onset diabetic group. Carotid
stenosis is one of the main causes of cerebrovascular
events, and the degree of carotid stenosis is also a valid
marker of the risk of cerebrovascular events. Therefore,
the presence of carotid artery stenosis can be used as an
indicator to select patients for interventional procedures
among ketosis-prone diabetics, especially in asymptomatic
subjects.Similarly to carotid atherosclerosis, the mean CIMT
value showed a significant increase in the ketosis-onset
diabetic subjects in comparison to the control subjects.
Additionally, in ketosis-onset diabetes the mean CIMT
value was directly related to the age of the patients, and
the elderly patients had a higher mean CIMT value com-
pared with younger patients consistent with findings
made by previous investigators [16,38-41]. Interestingly,
we could not find gender differences in CIMT values in
the ketosis-onset diabetic patients, and this was in ac-
cordance with a previous study in children with type 1
diabetes mellitus [40]. We speculate that it may also be
due to small sample size and uneven gender distribution
in the ketosis-onset diabetic group. The measurement
of the IMT of carotid arteries assessed by ultrasound
is often used to detect early atherosclerotic lesions and
is considered as a surrogate marker of subclinical athero-
sclerosis. Numerous studies have demonstrated that both
type 1 and type 2 diabetic patients had significantly higher
CIMT than control subjects. For example, Järvisalo et al.
demonstrated that children with type 1 diabetes had in-
creased carotid IMT compared to control subjects based
on ultrasound examination [8]. Additionally, Pujia et al.
observed that type 2 diabetes subjects had larger CIMT
compared with control subjects [39]. It is well-established
that increased CIMT is associated with cardiovascular risk
factors such as metabolic syndrome (MS) and insulin re-
sistance (IR), coronary atherosclerosis, and cardiovascular
events [42-47]. Herder et al. found that MS was associated
with CIMT and progression of CIMT [47]. Subjects with
MS have higher levels of CIMT at follow up than those
without MS [47], which indicate MS may be involved in
the initiation of the process of atherosclerosis. Further-
more, subjects with MS have significantly higher incidence
of subclinical carotid atherosclerosis and cardiovascular
events than subjects without MS, irrespective of its several
definitions [48]. Obesity is closely associated with IR and
MS. However, even in non-obese adolescent type 1 dia-
betes, CIMT is increased and also associated with IR [46].
Thus, IR may be used an important factor reflecting early
signs of atherosclerosis in type 1 diabetes. We therefore
hypothesise that an increase of CIMT in diabetic patients
with ketosis-onset may also result in a higher risk of car-
diovascular disease in the future.
Consistent with other studies [33,49-51], we found
that some of the traditional risk factors for atherosclerosis
were also present in the patients with ketosis-onset dia-
betes. As expected, age, hypertension, LDL-C, and CIMT
were independently associated with the presence of
carotid atherosclerosis in the ketosis-onset type 2 diabetes.
Therefore, strict control of hypertension and dyslipi-
daemia is important in order to prevent atheroscle-
rosis in the carotid arteries in diabetic patients with
ketosis-onset.
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Some limitations need to be considered for this study.
The cross-sectional design limits our ability to infer a
causal relationship between diabetic ketosis and the oc-
currence of carotid atherosclerosis. Further research is
needed to investigate the long-term effects of diabetic
ketosis on atherosclerosis in ketosis-prone diabetes. In
addition to small sample size, the present study was also
limited by the fact that ketosis-onset diabetic patients
were not gender-matched because of the well-recognised
predominance of ketosis-onset diabetes in males. Further
studies with larger cohorts will be necessary to determi-
ne the prevalence of atherosclerosis in ketosis-onset type
2 diabetes. Finally, because of the lack of a type 1 dia-
betic group, the difference of carotid atherosclerotic le-
sions between type 1 diabetics and ketosis-onset diabetics
could not be compared.
Conclusions
In conclusion, ketosis-prone type 2 diabetes was com-
mon among Chinese patients with new-onset diabetes.
The prevalence and risk of carotid atherosclerosis in
ketosis-onset diabetics without islet-associated autoanti-
bodies were significantly higher than that of control sub-
jects without diabetes but similar to that of non-ketotic
type 2 diabetic subjects. The characteristics of carotid
atherosclerotic lesions in ketosis-onset diabetes resemble
those of type 2 diabetes. The presence of carotid athero-
sclerosis was significantly associated with age, hyperten-
sion, LDL-C and CIMT in the ketosis-onset diabetes.
The present study provides further evidence to support
the classification of ketosis-prone diabetes as a subtype
of type 2 diabetes rather than idiopathic Type I diabetes
in adults.
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